un-audited Financial Results for the quarter ended 30.06.2026

SAMSRITA LABS LIMITED To, Date: 13.08.2026 1. BSE Limited 2. Metropolitan Stock Exchange of India Limited P.J. Towers, Dalal Street, 205(A). 2™ Floor, Piramal Agastya Corporate Park. Mumbai-400 001 Kamani Junction, LBS Road, Kurla (West), Scrip Code: 539267 Mumbai-400 070 Symbol: SAMSRITA Sub: Outcome of Board Meeting held on 13.08.2026 under Regulation 30 & 33 of SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015 Unit: Samsrita Labs Limited Dear Sir/Madam, With reference to the above mentioned subject, this is to inform the Exchanges that the meeting of the Board of Directors of Samsrita Labs Limited held on Thursday, 13.08.2026 at the registered office of the Company situated at 6-3-354/13/B2, Flat. No. B2, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad-500082, Telangana, the following items were Considered and approved. 1. Un-audited Standalone and Consolidated financial results for the quarter ended 30® June, 2026 (enclosed). 2. Limited Review Reports (Standalone and Consolidated) given by Statutory Auditors of the Company for the quarter ended 30™ June, 2026 (enclosed) The Board Meeting Commenced at 3.30 p.m and concluded at 4.00 p.m This is for the information and records of the Exchanges, please. Thanking you, Yours sincerely For Samsrita Labs Limited K. Krishnam Raju Chairman & Whole time Director DIN: 00874650 End: As above Regd.Off & Corp Off: 6-3-354/13/B2, Suryateja Apartments, Hindinagar, Punjagutta, Hyderabad.500082. L85110TG1996PLC0E9m9ai1li9d 8+ info@drhlsl.com, pcproductsindia@gmail.com, cs@drhlsl.com Contact N0.9490424639, Website: www.drhlsl.com STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTERI ENDED 30TH JUNE, 2026 (INR In Lakhs) Quarter Ended 3Months Ended | Preceding 3 | Corresponding 3 | Previous Year 30/6/2026 | Months Ended | months ended in |Ended 31 31/03/2026 previous year 03.2026 30/06/2025 UnAudited Audited UnAudited T [Revenue from Operations - 181 - I [Other Income - 315 - T [Total Revenue @+ - 296 - 296 [V [Expenses Cost of Material Consumed - - - - Purchase of Stock-in-trade - 165 - 165 Changes in inventories of finished goods, Workin progress and Stock in trade - - - - Employee benefits expenses 980 783 553 3911 Finance Costs - - - - Depreciation and Amortisation expenses 012 003 0,03 014 Other Expenses 2155 732 1210 83266 Total Expenses 3147 1683 27.66 87356 [V [Profit/(Loss) from before Exceptional Items and tax 01v) (3147) (a1.87) (27.66) (868.60) VI |Exceptional ltems - - . . VI |Profit/(Loss) before tax (V-VI) (3147) (11.87) (27.66)’ (868.60) VI _[Tax Expense: Current Tax - B B - Deferred Tax - - - - X [Profit/ (Loss) for the period from Continuing operations (VI-VII) (6147) a187) (27.66) (868.60) X [Prefit/ (Loss) from discontinuing operations - - - - X! |T ax Expense of discontinuing operations - - - B X0 |Profit/ (Loss) for the period from discontinuing operations after tax (X-XI) XII_[Profit/ (Loss) for the period (IX+XI) (3147) aLen (27.66) (868.60) XIV_|Other Comprehensive Income A) () Items that will not be reclassified to profit or loss (ii) Income Tax related to items that will not be relclassified to profit or loss. (B) () Items that will be reclassifed to proofr ilotss (i) Income Tax relating to ms that will be reclassified to profit or loss i i XV | period (XIII+XIV) (Comprising Profit (loss) and Other Comprehensive Income for the Period) G147) a187) (27.66) (868.60) XVI |C ompreInhcoeme nattsribiutavblee to Non Controlling Interest - - - - XVI |C ompreInhcoeme nattsribiutavblee to |Owneofr tshe company 6147) 187 (27.66) (868.60) XVIIT |Eamings Per Equity Share (For Continuing (Operations) (Face Value INR 10/- each) 1) B: ©14) (0.06) ©.19) (@.25) 2) Diluted (014) (0.06) ©.19) (@.25) XX |Eamings Per Equity Share (For Discontinued Operations) (Face Value INR 10/-each) 1) Basic 2) Diluted - - - - XX |Eamings Per Equity Share (For Continued and Discontinued Operations)(Face Value INR 10/- each) 1 B (014) (0.06) (©.19) (4.25) 2) Diluted (014) (0.06) (0.19) (4.25) Y0 |Paid Up Equity Share Capital (Face Value of INR 10/- per share) 2,274.97 2,27497 1,480.87 2,274.97 1. The unaudited Standalone financial results for the quarter ended 30th June 2026 have been subject to a limited review by the statutory auditors, and reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held on Thursday, 13th August 2026, 2. The Financial Statements have been prepared in accordance with the recognition and measurement principles laid down in the Ind AS prescribed under Section 133 of Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rules, 2015 (@ amended) 3. The Company has only one reportable segment i.e., Health Care Sector. Hence, the separate disclosure on Segment information is not required, 4. The Previous year's/quarter's figures have been regrouped/rearranged wherever necessaty, for the purpose of comparison, For SAMSRITA LABS LIMITED Place : Hyderabad K Krishnam Raju Date: 13/08/2026 Chairman & Whole time Director (DIN 00874650) MGR & CO HYDERABAD OFF: Flat No: 101, Suranjana Empire Estates, CHARTERED ACCOUNTANTS Dwarakapuri Colony, Punjagutta, Hyderabad 500082 Independent Auditor’s Review Report on the Quarterly unaudited Standalone Financial results of Samsrita labs Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors, Samsrita Labs Limited. 1. We have reviewed the accompanying statement of unaudited financial results of Samsrita Labs Limited (“the Company™) for the quarter ended June 30,2026 and year to date results for the period April 01,2026 to June 30, 2026(“the Statement™) attached herewith, being submitted by the company Pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the Regulation”) 2. This Statement, which is the responsibility of the company’s Management and approved by the Board of Directors, has been Prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 “Interim Financial Reporting”, prescribed under Section 133 of the companies act, 2013 read with relevant rules issued there under and other recognised accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We Conducted our review of the statement in accordance with the Standard of Review engagement (SRE) 2410, “Review of Interim Financial Information Performed by the independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether financial results are free of material misstatements. A review Consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analyti and other review procedures. A review is substantially less in scope thag/a conducted in accordance with HO : BHIMAVARAM: 24-3-11/201, Suma Sri BO : MUMBALAIK:T House, Plot No C1 B 4/32., Residency, Main Street, Sriramapuram, Bhimavaram, Opp. Artist Village Busstand, Near Arenja Complex, Andhra Pradesh -534202 Sec8, CBD Belapur, Mumbai-400614. Phone: 9676399599 Email: camgr9@gmail.com MGR & CO HYDERABAD OFF: Flat No: 101, Suranjana Empire Estates, CHARTERED ACCOUNTANTS Dwarakapuri Colony, Punjagutta, Hyderabad 500082 4. Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit Opinion. 5. Based on our review conducted and Procedures performed as stated in Paragraph 3 as above, nothing has come to our attention that causes us to believe that the accompanying Statement of unaudited Financial results prepared in accordance with the recognition a [Showing first 8,000 characters — download PDF for full document]